Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma

P. A. Thompson; H. M. Prince; J. F. Seymour; D. Ritchie; K. Stokes; K. Burbury; M. Wolf; S. Peinert; T. Joyce; S. J. Harrison

doi:10.1038/bmt.2010.180

Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma

P. A. Thompson, H. M. Prince, J. F. Seymour, D. Ritchie, K. Stokes, K. Burbury, M. Wolf, S. Peinert, T. Joyce, S. J. Harrison

Leukemia

Research output: Contribution to journal › Letter › peer-review

17 Scopus citations

Original language	English (US)
Pages (from-to)	764-765
Number of pages	2
Journal	Bone marrow transplantation
Volume	46
Issue number	5
DOIs	https://doi.org/10.1038/bmt.2010.180
State	Published - May 2011

ASJC Scopus subject areas

Hematology
Transplantation

Access to Document

10.1038/bmt.2010.180

Cite this

@article{19b0af2918554be99b25550fdb25a492,

title = "Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma",

author = "Thompson, {P. A.} and Prince, {H. M.} and Seymour, {J. F.} and D. Ritchie and K. Stokes and K. Burbury and M. Wolf and S. Peinert and T. Joyce and Harrison, {S. J.}",

year = "2011",

month = may,

doi = "10.1038/bmt.2010.180",

language = "English (US)",

volume = "46",

pages = "764--765",

journal = "Bone marrow transplantation",

issn = "0268-3369",

publisher = "Nature Publishing Group",

number = "5",

}

TY - JOUR

T1 - Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma

AU - Thompson, P. A.

AU - Prince, H. M.

AU - Seymour, J. F.

AU - Ritchie, D.

AU - Stokes, K.

AU - Burbury, K.

AU - Wolf, M.

AU - Peinert, S.

AU - Joyce, T.

AU - Harrison, S. J.

PY - 2011/5

Y1 - 2011/5

UR - http://www.scopus.com/inward/record.url?scp=79955927624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955927624&partnerID=8YFLogxK

U2 - 10.1038/bmt.2010.180

DO - 10.1038/bmt.2010.180

M3 - Letter

C2 - 20676149

AN - SCOPUS:79955927624

SN - 0268-3369

VL - 46

SP - 764

EP - 765

JO - Bone marrow transplantation

JF - Bone marrow transplantation

IS - 5

ER -

Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this